• Home
• About Us
  • Strategy
  • History
  • Directors
  • Management
  • Corporate Governance
  • Corporate Directory
  • Disclaimer
• Our Businesses
  • Coridon
  • Celxcel
  • Allied Medical
• Investor Centre
  • Shareholder Services
  • Update Shareholder Details
  • Register for Email Alerts
  • Download Annual Reports
  • Analyst Reports
  • How to Invest
  • Investment Data
• News Room
  • ASX Announcements
  • Media
  • News
  • Analyst Coverage
  • Proactive Investors News
  • Videos
• Contact Us

You are here: Home › About › News › Coridon Demonstrates 100% Protection against Herpes Simplex Virus 2 using DNA vaccine

Coridon Demonstrates 100% Protection against Herpes Simplex Virus 2 using DNA vaccine